R. Nolan Townsend
2022
In 2022, R. Nolan Townsend earned a total compensation of $705.4K as Chief Executive Officer and Director at Lexeo Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $186,000 |
|---|---|
| Salary | $465,000 |
| Other | $54,432 |
| Total | $705,432 |
Townsend received $465K in salary, accounting for 66% of the total pay in 2022.
Townsend also received $186K in non-equity incentive plan and $54.4K in other compensation.
Rankings
In 2022, R. Nolan Townsend's compensation ranked 3,764th out of 5,760 executives tracked by ExecPay. In other words, Townsend earned more than 34.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,764 out of 5,760 | 35th |
Division Manufacturing | 2,131 out of 3,136 | 32nd |
Major group Chemicals And Allied Products | 1,032 out of 1,422 | 27th |
Industry group Drugs | 968 out of 1,323 | 27th |
Industry Biological Products, Except Diagnostic Substances | 226 out of 291 | 22nd |
Source: SEC filing on April 26, 2024.
Townsend's colleagues
We found one more compensation record of an executive who worked with R. Nolan Townsend at Lexeo Therapeutics in 2022.
2022
Jenny Robertson
Lexeo Therapeutics